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ABSTRACT
Enhancers are developmentally controlled tran-
scriptional regulatory regions whose activities are
modulated through histone modifications or histone
variant deposition. In this study, we show by
genome-wide mapping that the newly discovered
deoxyribonucleic acid (DNA) modification 5-hydro-
xymethylcytosine (5hmC) is dynamically associated
with transcription factor binding to distal regulatory
sites during neural differentiation of mouse P19 cells
and during adipocyte differentiation of mouse
3T3-L1 cells. Functional annotation reveals that
regions gaining 5hmC are associated with genes ex-
pressed either in neural tissues when P19 cells
undergo neural differentiation or in adipose tissue
when 3T3-L1 cells undergo adipocyte differenti-
ation. Furthermore, distal regions gaining 5hmC
together with H3K4me2 and H3K27ac in P19 cells
behave as differentiation-dependent transcriptional
enhancers. Identified regions are enriched in motifs
for transcription factors regulating specific cell
fates such as Meis1 in P19 cells and PPARc in
3T3-L1 cells. Accordingly, a fraction of hydroxy-
methylated Meis1 sites were associated with a
dynamic engagement of the 5-methylcytosine
hydroxylase Tet1. In addition, kinetic studies of
cytosine hydroxymethylation of selected enhancers
indicated that DNA hydroxymethylation is an early
event of enhancer activation. Hence, acquisition of
5hmC in cell-specific distal regulatory regions may
represent a major event of enhancer progression
toward an active state and participate in selective
activation of tissue-specific genes.
INTRODUCTION
Enhancers are essential non-coding elements of the
genome involved in long-distance cell-speciﬁc regulation
of gene expression and whose mutation can impact on
disease development (1). Although high sequence conser-
vation across species is a hallmark of enhancers regulating
neural gene expression during development (2), other
regulatory regions involved in pluripotency or heart for-
mation are weakly conserved (3,4). Hence, identiﬁcation
of enhancers cannot rely solely on their sequence conser-
vation but requires the analysis of speciﬁc chromatin
features such as histone post-translational modiﬁcations
(5–7), histone variant deposition (8,9) and nucleosome sta-
bility (10).
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Putative regulatory regions deﬁned by their DNAse I
hypersensitivity contain H2A.Z and H3.3 variants in
unstable nucleosomes, which are thought to facilitate
transcription factor engagement and enhancer activation
(8,11). In many instances, H2A.Z is associated with
regions of low 5-methylcytosine (5mC) content (12,13), a
characteristic shared with the active chromatin mark
H3K4me2 (14). Despite the low-C.G dinucleotide (CpG)
content of cell-speciﬁc enhancers (14), an implication of
deoxyribonucleic acid (DNA) methylation in the regula-
tion of their activity has been suggested (15–17). The dis-
covery that Tet dioxygenases can generate
5-hydroxymethylcytosine (5hmC) from 5mC (18,19) led
to the hypothesis that Tet could initiate active DNA
demethylation. The demonstration that Tet enzymes can
further process 5hmC in 5-formylcytosine (5fC) and
5-carboxylcytosine (5caC) and that the DNA glycosylase
TDG speciﬁcally cleaves 5fC and 5caC further supports
this hypothesis (20–22). Recent genome-wide mapping
studies in embryonic stem (ES) cells have revealed that
(i) 5hmC is enriched in gene bodies where it correlates
with gene expression levels, (ii) 5hmC is associated with
low gene expression when present at transcription start
sites [TSSs (23–28)] and (iii) 5hmC is found at binding
sites for pluripotency transcription factors in undifferenti-
ated ES cells (26,29–31). Nonetheless, information per-
taining to the dynamics of 5hmC in regulatory regions
and its relationship with enhancer activity during cell
differentiation is still missing. Interestingly, 5hmC tis-
sue levels are higher in differentiated cells than in stem
cells (32) and increase with age in neural cells (33),
suggesting that a dynamic modulation of cytosine
hydroxymethylation could occur at cell-speciﬁc tran-
scription regulatory regions during differentiation and
aging. In this study, we used a paralleled thorough
analysis of 5hmC dynamics during adipocyte and neural
differentiation to describe the relationship between
DNA hydroxymethylation, transcription factor bind-
ing and enhancer activation. Our data indicate that
hydroxymethylation of cytosine at occupied transcription
factor-binding sites dynamically correlates with cell-
speciﬁc enhancer activity.
MATERIALS AND METHODS
Cell culture and transfections
P19.6 mouse embryonal carcinoma cells were grown in
high-glucose Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM) containing 10% fetal calf serum (GIBCO) and
differentiated with 1 mM all-trans retinoic acid (RA) for
48 h. Enhancer assays of selected regulatory regions
cloned into the CpG-free luciferase expression vector
pCpGLCMV/EF1 (34) were run as described (17) on
P19 cells treated or not with 1mM RA for 48 h. Mouse
3T3-L1 preadipocytes were obtained from American Type
Culture Collection and cultured in high-glucose DMEM
supplemented with 10% bovine calf serum (Hyclone-
ThermoScientiﬁc). Mature adipocytes were harvested
after 8 days of differentiation as described (35).
Hydroxymethylated DNA and chromatin
immunoprecipitation
Genomic DNA obtained from cultured cells (DNeasy
Blood and Tissue kit, Qiagen) was sonicated to produce
fragments ranging from 200 to 500 bp. Hydroxyme-
thylated DNA immunoprecipitation (hMeDIP) used
20 mg of fragmented DNA, 2mg of rabbit polyclonal
antibody against 5hmC (Diagenode, CS-HMC-020) and
followed the same procedure as described for methylated
DNA immunoprecipitation (17). hMeDIP samples re-
covered from independent experiments in P19 and
3T3-L1 cells were pooled and sequenced using Illumina
Genome Analyzer IIx (Institut de Biologie, IBL, Lille,
France). H3K4me2, H3K27ac, Tet1 and Meis1 ChIPed
DNA recovered from 10 to 12 independent ChIP experi-
ments were pooled for library preparation and sequencing
using Illumina Genome Analyzer II at IGBMC
sequencing facility (Strasbourg, France) or at IBL. A
complete list of antibodies used in this study is provided
in Supplementary Table S1.
Selective chemical labeling assay
Selective chemical labeling (SCL) was performed in tripli-
cates with 500 ng of sonicated genomic DNA from P19
cells ± RA according to recommendations from the
Hydroxymethyl Collector kit (Active Motif).
FAIRE assay
Formaldehyde assisted isolation of regulatory elements
(FAIRE) was performed as described (36). Recovered
DNA was analyzed by real-time polymerase chain
reaction (PCR) on a CFX96 real-time system (Biorad,
France). All primer sequences are indicated in
Supplementary Table S1. Primers were synthesized by
Sigma-Aldrich.
Transcriptomic analysis
Ten micrograms of P19 RNA was used as template for
complementary DNA (cDNA) synthesis using the
Superscript Double-Stranded cDNA Synthesis Kit
(Invitrogen). Hybridization of the cDNAs and scanning
of the arrays (2006-08-03_MM8_60mer_expr) were per-
formed in triplicates at the NimbleGen service facilities
(Reykjavic, Iceland). Quantile normalization of the data
through the robust multi-array average algorithm and
all primary analyses were performed using the
ArraySTar software suite (DNAstar, Inc.). Regulated
genes were identiﬁed through calculations of fold-changes
(FC) in gene expression and were considered signiﬁcant
for FC greater than 2, with P< 0.02 as determined by a
Benjamini–Hochberg-corrected Student t-test. A similar
procedure was used to process 3T3-L1 transcriptomic
data from Mikkelsen et al. (6). Transcriptomic and
sequencing data have been deposited in the Gene
Expression Omnibus database under accession number
GSE27436.
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Bioinformatics
hMeDIP-seq data and ChIP-seq data for Tet1, Meis1,
H3K4me2 and H3K27ac in fastq format were mapped
onto chromosomes of the mus musculus genome (mm8
version) using bowtie (37). The .sam ﬁles were converted
to .bam ﬁles using SAMtools (38). The .bam ﬁles were
then processed to yield .wig ﬁles using MACS (39).
We developed our own peak-calling algorithm, which
considers each position of the signal in turn, looking for
genomic regions of length L bp within which at least n
genomic positions had signal values lying above a given
threshold t. Overlapping regions satisfying these con-
straints were then merged and considered as one single
peak. Assuming the data follow a Poisson distribution,
an approximate p-value P is associated to the value
chosen for threshold t according to:
P nb reads  tð Þ ¼ 1ÿ
X
i<t, i2N
ieÿ
i!
 
where m is the expected number of reads.
Looking for genomic regions where 5hmC varied dy-
namically on differentiation, we ﬁrst constructed the
un-normalized signed raw differential signal for P19 and
3T3 cells, as: 8position p, Sp ¼
diffSp ÿ
undiffSp, a positive
value for genomic position p meaning an increase in signal
for that position during differentiation. The peak-calling
algorithm was then applied to 5hmC differential signals
with parameters (n=4; L=65; P< 1eÿ16) yielding 5hmC
up-regulated and down-regulated genomic regions. The
algorithm was also used to treat P19 Tet1 and
Meis1 ChIP-seq signals with parameters (n=4; L=65;
P< 1eÿ11 for Meis1 and 4eÿ7 for Tet1).
Sequence conservation was analyzed by creating a
wiggle ﬁle from the ‘PhastCons17way’ ﬁle from
University of California, Santa Cruz (http://genome.
ucsc.edu, 10 April 2012, date last accessed), which de-
scribes conservation of DNA sequences between 17 verte-
brates. This wiggle ﬁle was used to plot the average
conservation scores of identiﬁed regions.
RESULTS
Mapping of chromatin mark dynamics during cell
differentiation defines distinct classes of 5hmC-associated
putative regulatory regions
To characterize the dynamics of 5hmC and its correlation
with those of active chromatin marks H3K4me2 and
H3K27ac [a hallmark of enhancer activation (7,40)]
during cellular differentiation, we used two distinct
mouse cell lines that undergo either neural differentiation
on RA addition [P19 embryonal carcinoma cells (41)] or
adipocyte differentiation on treatment with a differenti-
ation cocktail (DC) containing insulin, dexamethasone
and IBMX [3T3-L1 cells (6)]. Hydroxymethylated DNA
was recovered from both cells lines by immunopre-
cipitation (hMeDIP) with a speciﬁc polyclonal antibody
(Supplementary Figure S1a) and processed for deep
sequencing. As the use of 5hmC antibodies has been sug-
gested to introduce a bias toward genomic regions with
high CpG numbers compared with the SCL and GLIB
methods (23,24), average proﬁles of CpG density in
hMeDIP- (P19 cells) and SCL [cerebellum (24)] -
enriched regions were plotted (Supplementary Figure
S1b). Data showed that SCL-enriched regions were not
characterized by a lower CpG density compared with
hMeDIP-enriched regions (Supplementary Figure S1c).
Hence, CpG density is unlikely to impose a strong bias
on our analysis. However, it cannot be excluded that
certain 5hmC-containing regions with low CpG number
are not efﬁciently pulled down by our procedure.
As described for ES cells (25,28), 5hmC was found to be
particularly abundant in gene-rich regions of both P19
and 3T3-L1 cells (data not shown). When comparing
5hmC levels in undifferentiated versus RA-treated P19
cells, speciﬁc regions showed a remarkable increase in
5hmC levels as exempliﬁed with the meis1 locus, a
RA-activated gene (Figure 1a, Supplementary Table S2)
coding for a Hox cofactor (42). To determine whether
these variations in 5hmC levels were associated with
changes in levels of other active chromatin marks, we
ran H3K4me2 and H3K27ac ChIP-seq assays in P19
cells. Interestingly, H3K4me2 and H3K27ac also
increased in these regions on RA addition.
Hydroxymethylation of the meis1 promoter region was
not affected although H3K4me2 and H3K27ac raised
(Figure 1a). Finally, consistent with previous observations
(43), intragenic levels of 5hmC increased signiﬁcantly at
speciﬁc positions when meis1 was expressed in response to
RA. Similar dynamics were observed at the fatty acid-
binding protein 4 (fabp4) locus in 3T3-L1 cells. Indeed,
this activated gene (Supplementary Table S3) showed
correlated elevation of 5hmC, H3K4me2 and H3K27ac
levels in intragenic and distal putative regulatory regions
but not immediately upstream of the TSS (Figure 1b).
Hence, differentiation-associated chromatin remodeling
in intragenic regions and putative distal regulatory
regions involves hydroxymethylation of DNA. This
provided a rationale for the further characterization of
regions that gain hmC (‘5hmC-up’ regions) during cell
differentiation.
To allow genomic annotation, 5hmC-up regions were
identiﬁed genome wide through direct comparison of our
hMeDIP-seq data from undifferentiated and differentiated
P19 and 3T3-L1 cells, as described in ‘Materials and
Methods’ section (Supplementary Tables S4 and S5). We
then generated heatmaps of 5hmC signals on 5hmC-up
regions rank ordered according to their 5hmC content in
the presence of RA (Figure 2a) or DC (Figure 2b), using
Cistrome (44). As shown in these heatmaps, peak calling
efﬁciently identiﬁed 5hmC-up regions in both cell lines.
Cis-regulatory Element Annotation System (45) indicated
that genomic distribution of 5hmC-up regions differed
between the two cell lines as intergenic regions were
highly represented in P19 compared with 3T3-L1
(Figure 2c and d), indicating that the DNA hydroxy-
methylation machinery was mobilized to different
genomic locations during adipocyte and neural differenti-
ation. We next questioned to what extent differentiation-
regulated genes were associated with 5hmC-up regions in
P19 and 3T3-L1 cells by analyzing the percentage of
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activated and repressed gene regions (±20kb of TSS),
which contained 5hmC-up peaks (Figure 2e and f).
Overall, the localization of 5hmC-up regions was biased
toward activated genes in both cell lines. Consistent with
the respective differentiation potential of P19 and 3T3-L1
cells, functional annotation of 5hmC-up regions using
genomic regions enrichment of annotations tool
(GREAT) (46) revealed that regions identiﬁed in P19
cells were associated with stem cell differentiation process
and genes expressed in neural tissues, whereas regions
identiﬁed in 3T3-L1 cells were associated with fat cell dif-
ferentiation process and genes expressed in adipose tissue
(Figure 2g and h). Interestingly, a highly signiﬁcant asso-
ciation with peroxisome proliferator activated receptor
(PPAR) signaling was observed for 3T3-L1 cells (Figure
2h).
We next used clustering to group 5hmC-up regions ac-
cording to both their 5hmC and H3K4me2 signals
(Figure 3). Clusters were analyzed for CpG density, con-
servation among vertebrates, H3K27ac signal and
annotated according to their genomic location (Figure 3a
and b and Supplementary Figure S2a and b). Remarkable
general features were recovered from this analysis: (i) the
center of 5hmC-up regions showed peaks of CpG density
and peaks of sequence conservation in both P19 and
3T3-L1 cells; (ii) 5hmC-up regions with less than 5%
of promoters (i.e. clusters C3, C4 and C5 in P19 cells
and C6 and C7 in 3T3-L1 cells) showed a centered gain
of H3K4me2 and H3K27ac. Collectively, these data
suggest that 5hmC-up regions harboring centered and
differentiation-induced peaks of H3K4me2 and H3K27ac
signals represent conserved regulatory regions bearing
characteristics of cell-type-speciﬁc enhancers.
Dynamic regulation of 5hmC-associated enhancers during
neural differentiation
To investigate whether the identiﬁed dynamic chromatin
signatures could mark enhancers dynamically regulated by
RA in P19 cells, we selected ﬁve regions lying in the
vicinity of RA-regulated genes and gaining 5hmC,
H3K4me2 and H3K27ac (Figure 4a). Fluctuations in
5hmC levels during differentiation were ﬁrst validated
through hMeDIP-qPCR (Figure 4b). RA-dependent
hydroxymethylation of these ﬁve regions was conﬁrmed
through SCL-qPCR (Supplementary Figure S3a).
Furthermore, bisulﬁte sequencing of genomic DNA
indicated that CpGs from regions 1 to 5 were heavily
methylated in undifferentiated P19 cells (Supplementary
Figure S3b), providing substrates for hydroxylation
(18,19). To further investigate the relationship between
5hmC and enhancer activation, we measured H3K27me3
and H3K27ac [two marks of poised and active
enhancers, respectively (7,40)] enrichment by chromatin
immunoprecipitation-quantitative polymerase chain
reaction (ChIP-qPCR). Variations in H3K27ac enrich-
ment mirrored those in 5hmC levels (Figure 4c), whereas
H3K27me3 was not detected in these regions (Figure 4d).
To verify that these enhancers indeed had temporally
H3K27ac +RA
H3K27ac -RA
(a)
H3K4me2 +RA
H3K4me2 -RA
5hmC +RA
5hmC -RA
coordinates
refseq(-)
50kb +1
H3K27ac +DC
(b)
M
AC
S 
sc
o
re
Meis1
H3K27ac -DC
H3K4me2 +DC
H3K4me2 -DC
5hmC +DC
5hmC -DC
coordinates
refseq(-)
5kb
+1
M
AC
S 
sc
o
re
Fabp9 Fabp4
Figure 1. Coordinated variations of chromatin marks deﬁne putative regulatory regions. (a) Integrated genome browser representation of ChIP/
hMeDIP-seq signals at the meis1 locus on mouse chromosome 11 in P19 cells. Putative regulatory regions (highlighted in gray upstream and
downstream of meis1) were characterized by an elevation in 5hmC, H3K4me2 and H3K27ac levels, whereas 5hmC levels at promoter region
(highlighted in brown) were not affected. (b) Integrated genome browser representation of ChIP/hMeDIP-seq signals at the fabp4 locus on mouse
chromosome 11 in 3T3-L1 cells. ChIP-seq data were from Mikkelsen et al. (6) and were recovered from Gene Expression Omnibus (GEO) database
(GSE20752). Highlighted regions are as in (a).
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controlled activities during P19 cell neural differentiation,
we monitored the relative nucleosomal depletion/stability
of these chromatin regions using FAIRE-qPCR
[formaldehyde-assisted isolation of regulatory elements
(47)]. Consistent with the requirement for an open chro-
matin structure at active enhancers, nucleosome density/
stability decreased in these regions during differentiation
(Figure 4e). DNA from the selected regions was next
cloned in a luciferase reporter vector bearing a minimal
promoter and transfected in P19 cells. Among the ﬁve
cloned sequences, four showed moderate to high
RA-activated enhancer activities (Figure 4f). Thus,
integrating DNA hydroxymethylation and histone mark
dynamics efﬁciently identiﬁed enhancers which were
activated during RA-driven P19 cell differentiation.
5hmC-based chromatin signatures identify a subset of
transcription factor-targeted enhancers
As enhancer activity is regulated through transcription
factor binding to DNA (48), we interrogated 5hmC-up
clusters for the presence of known transcription factor-
binding motifs with the Seq-Pos motif tool from
Cistrome. Among the retrieved motifs, PBX1 and its
three amino-acid loop extension (TALE)-homeodomain
(HD) partner PKNOX2 motifs were enriched in P19
cluster C4 (Figure 5a). CEBP and PPAR motifs were
(a) (c) (b) (d)
(f)(e)
(g) (h)
Figure 2. Functional annotation of 5hmC-up regions in P19 (left) and 3T3-L1 (right) cells. (a and b) Heatmap representations of 5hmC enrichment
in identiﬁed 5hmC-up regions (5 kb ﬂanking the center of 5hmC-up called regions). (c and d) Gene-centered annotation of 5hmC-up regions.
Annotation was run with Cistrome and is depicted as pie charts. Promoters are deﬁned as regions extending to 3 kb upstream of TSSs.
Downstream regions extend to 3 kb from transcription termination sites (TTSs). (e and f) Association of 5hmC-up regions with regulated genes.
Bars indicate the percentage of activated or repressed gene regions (±20kb around TSS), which overlap with 5hmC-up regions (5hmC) or random
regions (random). (g and h) P19 (g) and 3T3-L1 (h) 5hmC-up regions were analyzed with GREAT, and results concerning biological processes (GO
biological process), signaling pathways (MsigDB pathway) and tissue-speciﬁc expression (MGI expression detected) of the genes associated with
5hmC-up regions are shown.
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particularly enriched in 3T3-L1 clusters, especially in C7
(Figure 5c). The enriched motifs were conﬁrmed through
the CENTDIST algorithm (53), which uses position to
center of sample peaks to rank the identiﬁed motifs and
were identiﬁed both in intergenic and intronic 5hmC-up
regions (Supplementary Figure S4). Identiﬁcation of these
motifs was relevant to our differentiation models as Pre-B
cell leukemia homeobox (PBX) and their TALE-HD
protein partners Meis, TG-interacting factor and
peroxisome proliferator activated receptor (PKNOX)
(a) (b)
Figure 3. Characterization of differentiation-dependent hydroxymethylated genomic regions in P19 (a) and 3T3-L1 cells (b). Heatmaps represent
5hmC and H3K4me2 proﬁles in clusterized 5hmC-up regions. Clustering was run with Cistrome taking into account all signals. Clustering param-
eters were adjusted for each cell line to obtain a minimal number of clusters with homogeneous distribution of signals. Horizontal lines demarcate the
different clusters and the number of regions lying within each cluster is given in brackets. Average proﬁles of CpG density, conservation among
vertebrates and H3K27ac were generated for each cluster of 5hmC-up regions and are shown for P19 cluster C4 and 3T3-L1 cluster C6.
Gene-centered annotation of clusters is depicted as rings.
Figure 4. Regions deﬁned by coordinated variations in 5hmC, H3K4me2 and H3K27ac in P19 cells are RA-dependent enhancers. (a) Table
indicating the genomic coordinates of selected 5hmC-up regions cloned in a luciferase reporter vector and their position relative to RA-regulated
genes. (b) Validation of 5hmC variations in selected regions by hMeDIP-qPCR shown as relative enrichment (percentage of input). (c) ChIP-qPCR
analysis of H3K27ac enrichment of selected regions. The open chromatin of the Hus1 promoter served as a positive control, whereas ampliﬁcation of
a region within Nf1a on chromosome 4 provided a negative control. Results are shown as mean±SEM of biological duplicates. (d) ChIP-qPCR
analysis of H3K27me3 enrichment of selected regions. Negative and positive controls are as in (c). Results are shown as mean±SEM of biological
duplicates. (e) FAIRE assay of nucleosome depletion/stability in selected regions. Results are shown as mean±SEM of biological triplicates. (f)
Luciferase reporter assay of the cloned regions ÿ/+ RA. Negative control indicates relative luciferase activities obtained after transfection of the
empty control vector.
6 Nucleic Acids Research, 2012
 at S
C
D
 U
niversitÃ
©
 P
aris 5 on July 11, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
play crucial role in development (42) and are required for
P19 cell differentiation (54), whereas CCAAT enhancer
binding protein beta and PPARg are required for
adipogenesis (55).
As Meis1 binds as a complex with PBX1 to a
brain-speciﬁc enhancer (56), we next decided to identify
Meis1 genome-wide binding sites in RA-treated P19 cells
through ChIP-seq (Supplementary Figure S5). Although
Meis1 sites were particularly enriched in introns and
intergenic sequences (Supplementary Figure S5), 14% of
Meis1 peaks were located in CpG islands (CGIs). Of note,
de novo motif prediction on Meis1 high-conﬁdence peaks
identiﬁed not only Meis1- and PBX-binding sequences but
also CA repeats in a large fraction of Meis1-binding
regions (11 207 of 36 044 regions—Supplementary
Figure S5). As CA repeats have been shown to be
enriched by hMeDIP but not by GLIB or SCL procedures
(57), and regardless of the potential relevance of these CA
repeat-containing regions in Meis1 binding and function,
these regions were excluded from the analysis of Meis1-
binding sites throughout this study. Consistent with the
retrieved motifs, average proﬁles of Meis1 ChIP-seq
signal indicated that Meis1 binds and peaks at the center
of P19 5hmC-up regions (Figure 5b). Similarly, using
PPARg ChIP-seq data from Nielsen et al. (49), we found
PPARg binding to 3T3-L1 5hmC-up regions (Figure 5d).
The variations in 5hmC levels were validated by hMeDIP-
qPCR for selected PPARg-bound enhancers (Supplemen-
tary Figure S6). Hence, cell-speciﬁc hydroxymethylated en-
hancers are bound by transcription factors regulating cell
(a) (b) (c) (d)
(e) (f)
Figure 5. 5hmC-up regions are enriched in cell-speciﬁc transcription factor binding motifs. (a) Logos of transcription factor-binding motifs enriched
in cluster C4 of 5hmC-up regions from P19 cells. Clusters were scanned (500 bp around peak center) for transcription factor motifs with the SeqPos
motif tool from Cistrome, using Transfac matrices. (b) Average proﬁle of Meis1 binding to regions from clusters C4 and C5 in P19 cells treated
with RA for 48 h. (c) Examples of transcription factor-binding motifs enriched in 5hmC-up regions from 3T3-L1 cluster C7. (d) Average proﬁle of
PPARg binding to clusters C6 and C7 regions in differentiated 3T3-L1 cells. Proﬁles were generated with GSM340799 from Nielsen et al. (49).
(e and f) Heatmap representations of hMeDIP-seq signal at Meis1 (e), PPARg- and CEBPa-(f) -binding sites rank ordered according to signal in
the presence of differentiation inducer and classiﬁed into non-CGI and CGI sites. PPARg sites represent pooled sites from GSM535769 and
GSM535770 (6), GSM686980 (50) and GSM532740 (51) after removal of redundant binding events. CEBPa sites are from GSM678392 (52).
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differentiation. To get further insight into the distribution
of 5hmC at transcription factor-binding sites and the pro-
portion of sites that become hydroxymethylated on differ-
entiation, we then generated heatmaps of Meis1 and
PPARg-binding sites according to their 5hmC signal
(Figure 5e and f) with binding regions divided into CGIs
and non-CGIs. As already described by others (26,57),
5hmC signal in CGIs was low and did not increase with
differentiation (Figure 5e and f). Conversely, almost all
non-CGI Meis1 sites gained 5hmC in RA-treated cells re-
gardless of Meis1 signal. A differentiation-dependent
hydroxymethylation of cytosines was also observed for
PPARg- and CEBPa-binding regions in 3T3-L1 cells
(Figure 5f).
To determine the sequence of events occurring at enhan-
cers during differentiation, we then analyzed the kinetics
of DNA hydroxymethylation, H3K27 acetylation and
Meis1 recruitment at enhancers R1 to R5 during the
ﬁrst 48 h of RA-induced P19 cell differentiation. DNA
hydroxymethylation was either concomitant (R1, R2
and R5) with activation of enhancers or occurred before
(R3 and R4) activation (Supplementary Figure S7).
Hence, DNA hydroxymethylation might be an early
event of enhancer activation.
A fraction of hydroxymethylated Meis1-bound enhancers
recruits Tet1 during differentiation
Increased 5hmC levels at enhancers activated during dif-
ferentiation suggested that Tet enzymes could be recruited
to these regions. Hence, we mapped Tet1-binding sites in
P19 cells -/+RA through ChIP-seq assays. As described in
RA-treated ES cells, Tet1 expression decreased on P19 cell
differentiation to reach levels comparable with those of
Tet2 and Tet3 (Supplementary Figure S8). Consistent
with decreased expression, high-conﬁdence (P 3.eÿ7)
Tet1-binding regions dropped from 15 039 in undifferen-
tiated cells to 12 236 in RA-treated P19 cells. Similar to its
distribution in ES cells, Tet1 was enriched in promoters
(Supplementary Figure S9a) and in CGIs (Supplementary
Figure S9b). Despite its lower expression in RA-treated
cells, we identiﬁed 6096 high-conﬁdence Tet1-up sites
(P 2.4eÿ9) among which 824 were located in CGIs
(Supplementary Figure S9c). Interestingly, as evidenced
by heatmaps, most of these Tet1-up regions were
not associated with a gain in 5hmC (Supplementary
Figure S9d), indicating that Tet1 enzymatic activity
might be regulated at its binding sites and/or that Tet1
can serve additional functions as already suggested (25).
Further analysis evidenced that H3K27ac levels raised in
Tet1-up regions which became hydroxymethylated but not
in others (Supplementary Figure S9d).
We then examined the engagement of Tet1 at non-CGI
Meis1-binding sites and found that Tet1 associates with
a fraction of Meis1 sites, which shows an enrichment
in CpGs (Figure 6a and Supplementary Figure S10).
Through a second round of clustering, we identiﬁed
1306 regions (Figure 6a) that show, as exempliﬁed for
an intronic region of the bcas3 gene (Figure 6c), a simul-
taneous increase in Tet1 and DNA hydroxymethylation
levels during RA-induced differentiation. Interestingly, a
large fraction of these regions was already associated with
low levels of Tet1 in undifferentiated cells (Figure 6a) in
line with premarking of Meis1-binding sites by low levels
of 5hmC (Figure 5e). Although Tet1 loading decreased on
RA treatment at 613 speciﬁc Meis1-binding sites, average
5hmC levels increased by 40% (Figure 6b). These data
indicate a complex relationship between Meis1 and Tet1
and suggest that Meis1 engagement at Tet1-binding sites
could stimulate its recruitment and/or its activity.
DISCUSSION
Taken together, our data indicate a relationship between
DNA hydroxymethylation and enhancer activation during
mouse cell differentiation. Our observations are in line
with previous studies reporting an enrichment in 5hmC
at enhancers in correlation with H3K4me1, H3K4me2
and H3K27ac levels in undifferentiated human stem cells
(30,31) and that binding sites engaged with the
pluripotency transcription factor NANOG bear 5hmC.
On differentiation, ES cells tend to lose 5hmC, and it
remains unknown whether the mark is lost in a general
way or if speciﬁc genomic regions can become hydroxy-
methylated during programming of alternative cell states.
In this study, we provide evidence that differentiation is
associated with dynamic DNA hydroxymethylation of a
subset of cell-type-speciﬁc enhancers.
Pioneer studies focusing on the genome-wide distribu-
tion of 5hmC showed that intragenic 5hmC is positively
associated with gene activity (26,29,58). Consistent with
this observation, 5hmC inhibits binding of several
Methyl CpG binding protein (MBD) including MeCP2
(59, 60) and could reduce maintenance methylation by
DNMT1 (61). As MeCP2 recruits enzymatic systems
that drive chromatin condensation (62–64), oxidation of
5mC could help chromatin opening and thereby facilitate
gene expression. As demonstrated for FOXA1-dependent
enhancers, chromatin opening at enhancers is associated
with their cell-speciﬁc activity (36). In this study, we es-
tablish that chromatin opening, as assessed by FAIRE, is
associated with acquisition of 5hmC at selected enhancers.
In parallel to the gain in 5hmC, H3K27 acetylation levels
raised, suggesting a model of enhancer activation that
involves the conversion of 5mC to 5hmC. In line with
this hypothesis, a recent study of glucocorticoid receptor
(GR)-bound enhancers suggested that a fraction of GR
sites distal to TSS and outside of CGIs are demethylated
on GR binding (65). Similar to what is observed for
5hmC-up regions deﬁned in this study, these enhancers
are characterized by a peak of CpG density that is also
observed for DNAse I hypersensitive sites not overlapping
with CGIs (65), hence deﬁning a category of enhancers
that show intermediate CpG density (compared with
CGIs and the rest of the genome) and whose activity is
controlled by methylation. Recently, Schu¨beler and
coworkers (66) described methylome remodeling through
transcription factor binding at enhancers with low to
intermediate levels of CpGs and associated with Tet1. It
is most likely that 5hmC-up regions identiﬁed in P19 and
3T3-L1 cells belong to this particular category of
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enhancers implying that loss of methylation at these sites
actually results from hydroxylation by Tet enzymes, then
leading to chromatin activation. Although we cannot
exclude that the observed CpG density of these
5hmC-up regions reﬂects a bias due to the antibody-based
5hmC capture, they show striking similarities with the
aforementioned GR-bound enhancers. Indeed, these
regions have intermediate CpG density levels, bind tran-
scription factors and harbor active chromatin marks when
hydroxymethylated. We propose that Meis1 activation of
enhancers enriched in CpGs involves engagement of Tet
enzymes (Supplementary Figure S11). Indeed, we have
shown in this study that Tet1 was recruited to a subset
of Meis1-bound enhancers.
The data presented herein argue for a positive role of
active DNA demethylation through conversion of 5mC to
5hmC in the regulation of enhancer activity. This could be
a transitory state toward replacement of modiﬁed cyto-
sines by cytosines through base excision repair (20), but
5hmC levels seem to be quite stable over time both in P19
and 3T3-L1 cells. Indeed, we observed that enhancers that
gain 5hmC at 48 h post RA or DC addition are still
hydroxymethylated 7 days after beginning of the treat-
ment (data not shown). This relative stability of 5hmC
levels at enhancers suggests that 5hmC could be a signal-
ing mark rather than a short-lived intermediate of active
DNA demethylation. Such signaling would involve
putative hydroxymethyl-DNA-binding proteins regulating
chromatin activity. Alternatively, 5hmC stability could
merely protect active enhancer DNA from remethylation
and recognition by MBDs. Consistent with the hypothesis
that 5hmC is a mark of active enhancer rather than an
intermediate in DNA demethylation, we noticed that
loss of 5hmC in 5hmC-down regions from P19 cells
was correlated with a decrease in active chromatin
marks (Supplementary Figure S12 and Supplementary
Table S6). In accordance with chromatin inactivation,
motif search in 5hmC-down regions revealed a highly
signiﬁcant enrichment in putative binding sites for
pluripotency transcription factors SF1, ESRRB and
LRH1 [Supplementary Figure S12d (67–69)]. Importantly,
SF1 is known to activate the Oct3/4 promoter in P19 cells,
and its expression is dramatically reduced on RA addition
(67). Hence, loss of transcription factor binding during
differentiation is likely to promote chromatin inactivation
and 5hmC erasure at target enhancers.
Collectively, our data support and extend the concept of
transcription factor shaping the methylome at distal regu-
latory regions by indicating that stable hydroxymethyla-
tion of DNA associates with transcription factor binding
and activation of enhancers.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online: Sup-
plementary Tables 1–6 and Supplementary Figures 1–12.
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